Lam Vinh Sieu, Huynh Kim Huyen, Tran Phillip
Cardiovascular Research Department, Methodist Hospitals, Merrillville, USA.
Faculty of Medicine, Moscow State University of Medicine and Dentistry, Moscow, RUS.
Cureus. 2025 Jul 24;17(7):e88663. doi: 10.7759/cureus.88663. eCollection 2025 Jul.
The wearable cardioverter-defibrillator (WCD), or LifeVest (ZOLL Medical Corporation, an Asahi Kasei company, Tokyo, Japan), is designed for continuous monitoring and immediate treatment of patients at high risk of sudden cardiac arrest (SCA). Due to a lack of water resistance and inability to operate safely in wet conditions, current guidelines recommend wearing the device at all times except for short periods, such as during showering. We present the case of an 88-year-old male with complex coronary artery disease, ischemic cardiomyopathy, and permanent atrial fibrillation who experienced cardiac arrest and ventricular fibrillation (V-Fib) during a shower when not wearing his LifeVest. Immediately after he lost consciousness, his wife promptly reattached the LifeVest, which stabilized his condition with a shock delivered by the device. This case highlights potential risks during device-free periods and the limited data on compliance and outcomes in these intervals. Further study is needed to assess risks and explore solutions that allow for the device's removal for short periods and enhance the patient's safety.
可穿戴式心脏复律除颤器(WCD),即LifeVest(日本东京旭化成公司旗下的卓尔医疗公司生产),专为持续监测和即时治疗心脏骤停(SCA)高危患者而设计。由于缺乏防水性且无法在潮湿环境中安全操作,当前指南建议除短时间(如淋浴期间)外,应始终佩戴该设备。我们报告了一例88岁男性患者的病例,该患者患有复杂冠状动脉疾病、缺血性心肌病和永久性心房颤动,在未佩戴LifeVest淋浴时发生心脏骤停和心室颤动(室颤)。他失去意识后,其妻子立即重新为他佩戴上LifeVest,该设备通过电击使他的病情稳定下来。该病例凸显了设备未佩戴期间的潜在风险以及这些时间段内关于依从性和治疗结果的有限数据。需要进一步研究以评估风险并探索允许短时间取下设备并提高患者安全性的解决方案。